We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
(+81%)
Cap. Flow
+$4.58B
Cap. Flow
% of AUM
34.18%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$437M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
Amazon
AMZN
|
+$185M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$51.4M |
| 2 |
Lowe's Companies
LOW
|
+$45.3M |
| 3 |
CVS Health
CVS
|
+$37.3M |
| 4 |
Eli Lilly
LLY
|
+$32.7M |
| 5 |
Southern Company
SO
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Consumer Discretionary | 11.59% |
| 3 | Healthcare | 8.66% |
| 4 | Financials | 6.8% |
| 5 | Industrials | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Keros Therapeutics
KROS
$199M
| $637K | ﹤0.01% |
+9,035
| New | +$569K |
|
|
HBI
1627
DELISTED
Hanesbrands
HBI
| $636K | ﹤0.01% |
+43,640
| New | +$658K |
|
|
AVEO
1628
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $636K | ﹤0.01% |
110,179
+33,447
| +44% | +$191K |
|
1629
Coca-Cola Europacific Partners
CCEP
$46.5B
| $635K | ﹤0.01% |
12,744
-7,653
| -38% | -$323K |
|
1630
GameStop
GME
$9.5B
| $635K | ﹤0.01% |
134,768
-166,120
| -55% | -$572K |
|
1631
E.W. Scripps
SSP
$274M
| $631K | ﹤0.01% |
41,251
-45,266
| -52% | -$557K |
|
1632
Take-Two Interactive
TTWO
$43B
| $631K | ﹤0.01% |
3,035
-51,321
| -94% | -$8.97M |
|
1633
Arthur J. Gallagher & Co
AJG
$63.7B
| $627K | ﹤0.01% |
5,072
-54,352
| -91% | -$6.19M |
|
1634
LGI Homes
LGIH
$1.4B
| $627K | ﹤0.01% |
5,922
-7,768
| -57% | -$885K |
|
1635
Hope Bancorp
HOPE
$1.72B
| $626K | ﹤0.01% |
57,336
+10,452
| +22% | +$97.3K |
|
|
NGM
1636
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $625K | ﹤0.01% |
+20,618
| New | +$451K |
|
1637
CALL
Kraft Heinz
KHC
$30.4B
| $624K | ﹤0.01% |
18,000
-500
| -3% | -$16.2K |
|
|
1638
PUT
Kraft Heinz
KHC
$30.4B
| $624K | ﹤0.01% |
18,000
-600
| -3% | -$19.5K |
|
|
MAXR
1639
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $624K | ﹤0.01% |
16,176
-2,141
| -12% | -$62.9K |
|
|
TCRR
1640
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $623K | ﹤0.01% |
+20,154
| New | +$510K |
|
1641
Blink Charging
BLNK
$75.2M
| $622K | ﹤0.01% |
+14,543
| New | +$287K |
|
1642
HUB Group
HUBG
$3.01B
| $622K | ﹤0.01% |
21,826
-7,396
| -25% | -$200K |
|
1643
Ocugen
OCGN
$410M
| $622K | ﹤0.01% |
+339,651
| New | +$164K |
|
1644
Equity Bancshares
EQBK
$1.03B
| $621K | ﹤0.01% |
28,763
+18,326
| +176% | +$356K |
|
1645
California Water Service
CWT
$3.04B
| $620K | ﹤0.01% |
+11,477
| New | +$565K |
|
1646
Xencor
XNCR
$1.44B
| $620K | ﹤0.01% |
14,202
+7,502
| +112% | +$310K |
|
1647
Cardlytics
CDLX
$21M
| $619K | ﹤0.01% |
433
-72
| -14% | -$76.8K |
|
1648
Cemex
CX
$17.4B
| $619K | ﹤0.01% |
119,766
+39,572
| +49% | +$182K |
|
1649
Ducommun
DCO
$2.68B
| $619K | ﹤0.01% |
11,535
-16,175
| -58% | -$698K |
|
1650
LyondellBasell Industries
LYB
$19.5B
| $618K | ﹤0.01% |
6,741
-46,838
| -87% | -$3.82M |
|
Similar funds
Squarepoint's Q4 2020 Portfolio in Review
As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.
- Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
- Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
- Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
- Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
- Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
- Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.
Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.